secwatch.observer — SEC 8-K summary
======================================

Issuer:     Krystal Biotech, Inc. (KRYS)
CIK:        0001711279
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001711279-25-000092
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Krystal Biotech director Kirti Ganorkar resigns effective Dec 31, 2025
----------------------------------------------------------------------

- Kirti Ganorkar resigned from Krystal Biotech Board on Dec 22, 2025 due to time constraints from promotion to Managing Director at Sun Pharma.
- Resignation not due to disagreement with Board or management; effective Dec 31, 2025.
- Ganorkar served on Board since company's IPO in September 2017.
- Board thanks him for contributions; no successor identified in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711279/000171127925000092/0001711279-25-000092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711279/000171127925000092/krys-20251223.htm
  HTML page:      https://secwatch.observer/filing/0001711279-25-000092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer